SCHEMBL8762771

SCHEMBL8762771

Nc1c(Cl)cc(S(=O)(=O)NC(=O)Nc2ccc(Cl)cc2)cc1Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 10/20 0.54
CA12 O43570 9/20 0.54
CA1 P00915 9/20 0.54
CA9 Q16790 9/20 0.54
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
MAPT P10636 2/20 0.50
FBP1 P09467 1/20 0.50
NPC1 O15118 1/20 0.49
LMNA P02545 1/20 0.49
EPHX1 P07099 1/20 0.49
ADORA3 P0DMS8 1/20 0.49
CHRM1 P11229 1/20 0.49
SLC6A2 P23975 1/20 0.49
PDE4A P27815 1/20 0.49
EPHX2 P34913 1/20 0.49
ADRA1A P35348 1/20 0.49
OPRM1 P35372 1/20 0.49
HTT P42858 1/20 0.49
PDE3A Q14432 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8000981 0.88 CA12 (0.53) CA2CA12CA1CA9MEN1
SCHEMBL9487105 0.84 MEN1 (0.62) CA2CA12CA1CA9MEN1
SCHEMBL9486495 0.83 CA12 (0.66) CA2CA12CA1CA9MEN1
SCHEMBL8762861 0.82 PPARG (0.52) CA2CA12CA1CA9MEN1
SCHEMBL8762900 0.81 CA12 (0.57) CA2CA12CA1CA9MEN1
SCHEMBL8762903 0.80 CA12 (0.56) CA2CA12CA1CA9MEN1
SCHEMBL9529388 0.79 LMNA (0.63) CA2CA12CA1CA9MEN1
SCHEMBL9487941 0.78 FBP1 (0.79) CA2CA12CA1CA9MEN1
SCHEMBL9486556 0.78 MEN1 (0.67) CA2CA12CA1CA9MEN1
Ly-181984 SCHEMBL4612056 0.77 RECQL (0.74) CA2CA12CA1CA9MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0550157-B1 Antitumor compositions and methods of treatment LILLY CO ELI (US) 1997-07-23 EP claimed
EP-0550157-A1 Antitumor compositions and methods of treatment ELI LILLY AND COMPANY (US) 1993-07-07 EP claimed
EP-0550157-B1 Antitumor compositions and methods of treatment LILLY CO ELI (US) 1997-07-23 EP disclosed
US-5354778-A N-Phenyl-N'-substituted phenylsulfonylureas ELI LILLY AND COMPANY (US) 1994-10-11 US disclosed
US-5234955-A N-phenyl-N*-substituted phenylsulfonylureas ELI LILLY AND COMPANY (US) 1993-08-10 US disclosed
EP-0550157-A1 Antitumor compositions and methods of treatment ELI LILLY AND COMPANY (US) 1993-07-07 EP disclosed